This compound is primarily utilized in the field of medicinal chemistry as a key intermediate in the synthesis of biologically active molecules. Its structure, featuring a difluoropiperidine core, is often explored for its potential in drug development, particularly in the design of central nervous system (CNS) targeting agents. The presence of the benzyl and benzylidene groups enhances its ability to interact with specific receptors, making it valuable for creating compounds with potential therapeutic effects in neurological disorders. Additionally, its fluorine atoms contribute to improved metabolic stability and bioavailability, which are critical factors in pharmaceutical applications. Researchers also investigate its use in the development of enzyme inhibitors and receptor modulators due to its unique structural properties.